bims-mistre Biomed News
on Mito stress
Issue of 2026–11–08
thirteen papers selected by
Ellen Siobhan Mitchell, MitoQ



  1. J Ovarian Res. 2026 Aug 07. pii: 332. [Epub ahead of print]19(1):
       BACKGROUND: Mitochondrial dysfunction is a leading contributor to the decline in oocyte quality associated with maternal aging. Prior investigations of mitochondrial function in the ovarian follicle have largely treated the mitochondrial pool as a homogeneous population, reporting aggregate values that may obscure biologically meaningful differences between distinct mitochondrial subpopulations. The present study addresses this limitation by characterizing mitochondrial subpopulation dynamics in oocytes and cumulus granulosa cells at single-organelle resolution using fluorescence-activated mitochondria sorting (FAMS).
    RESULTS: Analysis of the aggregate mitochondrial population in mouse oocytes revealed no significant age-associated differences in mitochondrial DNA copy number or membrane potential, a result that would previously have been interpreted as evidence of minimal age-related mitochondrial change. Subpopulation analysis revealed this conclusion to be incomplete: aged oocytes showed significantly elevated mitochondrial DNA copy number specifically within the high membrane potential and small mitochondrial subpopulations, with no significant differences in the low membrane potential or large subpopulations. NMN supplementation normalized mitochondrial DNA copy number in the high membrane potential and small subpopulations toward young levels while producing an opposing effect in large mitochondria, demonstrating subpopulation-specific rather than uniform rejuvenation. In cumulus cells, significant age-associated changes were detectable at the aggregate level, including a reduction in mitochondrial DNA copy number and an elevation in membrane potential, and subpopulation analysis further resolved these findings. The age-associated reduction in cumulus cell mitochondrial DNA copy number was driven predominantly by the high membrane potential subpopulation. NMN supplementation exerted opposing effects on small and large cumulus cell mitochondrial subpopulations, increasing mitochondrial DNA copy number above both young and aged levels in small mitochondria while further reducing it below aged levels in large mitochondria.
    CONCLUSIONS: Viewing the mitochondrial pool as a heterogeneous mixture of functionally distinct subpopulations rather than a uniform population reveals age-associated alterations in oocytes and cumulus cells that are undetectable by aggregate analysis. NMN supplementation exerts subpopulation-specific effects in both cell types, identifying specific mitochondrial subtypes as more precise targets for future mechanistic investigation of age-associated infertility than the mitochondrial pool considered in aggregate.
    Keywords:  Cumulus granulosa cells; Membrane potential; Mitochondrial heterogeneity; NMN; Oocyte quality; Reproductive aging; mtDNA
    DOI:  https://doi.org/10.1186/s13048-026-02223-6
  2. Metab Brain Dis. 2026 Nov 05. pii: 251. [Epub ahead of print]41(1):
      Ammonia plays a pivotal role in the pathogenesis of hepatic encephalopathy (HE). Astrocytes are the principal site of ammonia detoxification in the brain, where ammonia is incorporated with glutamate to generate glutamine. After entering mitochondria, glutamine sequentially catabolized, leading to the re-release of ammonia and the generation of oxidative stress, thereby disrupting mitochondrial function. MitoQ, a mitochondria-targeted antioxidant, has been shown to protect against mitochondrial oxidative injury. This study investigated the therapeutic effects and underlying mechanisms of MitoQ in thioacetamide (TAA)-induced HE. MitoQ treatment alleviated TAA-induced behavioral abnormalities and reduced aberrant astrocyte activation in hippocampus. TAA-induced HE exhibited disrupted mitochondrial quality regulation in hippocampus, characterized by increased p-DRP1 expression, decreased OPA1 expression, and activation of PINK1, Parkin, and LC 3B, while these abnormalities were restored following mitochondria-targeted therapy. Primary astrocytes were isolated and exposed to 5 mM ammonium chloride to establish an in vitro hyperammonemic model, followed by treatment with 100 nM MitoQ. MitoQ reduced intracellular reactive oxygen species (ROS) and restored mitochondrial membrane potential in ammonia-exposed astrocytes. Transcriptomic analysis further indicated that oxidative phosphorylation, regulation of autophagy, and mitochondrial function were among the key pathways involved in the protective effects of MitoQ in astrocytes under hyperammonemic conditions. Importantly, PINK1 knockdown abolished the protective effects of MitoQ, suggesting that the PINK1/Parkin pathway is required for MitoQ-mediated mitochondrial protection. Together, these findings demonstrate that MitoQ attenuates TAA-induced HE by restoring mitochondrial homeostasis and suppressing astrocytic oxidative stress, at least partly through a PINK1/Parkin-dependent mechanism.
    Keywords:  Hepatic encephalopathy; MitoQ; Mitochondrial Quality Control; Mitophagy; PINK1/Parkin pathway
    DOI:  https://doi.org/10.1007/s11011-026-02014-4
  3. Basic Res Cardiol. 2026 Nov 03.
      Obesity and metabolic syndrome are major drivers of metabolic heart disease, characterized by profound cardiac energy deficits, structural remodeling, and progression to heart failure. While myocardial mitochondrial dysfunction in obesity is well established, its impact on coronary arteries remains underexplored. This study investigates how high-fat diet (HFD)-induced obesity affects coronary bioenergetics, mitochondrial REDOX balance, and endothelial function. Male Wistar rats were fed a HFD (60% kcal fat) for 15-16 weeks after weaning as a model of diet-induced obesity, and tunicamycin-treated rats as a model of chemically-induced ER stress in vivo were used. Myograph experiments to assess coronary endothelial function, reactive oxygen species (ROS) measurements, and mitochondrial respiration experiments in a Seahorse analyzer were comprehensively conducted. After 15-16 weeks of HFD rats developed metabolic syndrome features, including weight gain, hyperglycemia, hypertriglyceridemia, and elevated lactate. Coronary arteries exhibited endothelial dysfunction, evidenced by impaired acetylcholine- and isoprenaline-induced relaxations, mediated by NADPH oxidase 1 (NOX1)-derived ROS, as selective NOX1 inhibition (NoxA1ds-tat) restored vasodilation. Mitochondrial ROS (mtROS) levels increased in arteries but not myocardium, along with preserved hydrogen peroxide (H2O2)-mediated signaling. Protein analysis revealed down-regulated endothelial NOX4 and manganese superoxide dismutase (MnSOD), reduced respiratory complex IV (COX-IV) and uncoupling protein 2 (UCP2), and blunted mitochondrial respiration across basal, ATP-linked, and maximal states. Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) up-regulation indicated adaptive biogenesis. HFD also activated endoplasmic reticulum (ER) stress. Notably, tunicamycin-induced ER stress recapitulated these deficits, impairing relaxation, H2O2 production, and respiration, yet up-regulating protective NOX4/MnSOD/PGC-1α. These findings couple coronary mitochondrial impairment to obesity-driven heart disease, highlighting impaired coronary bioenergetics, mitochondrial oxidative stress, and ER stress as key mechanisms. Thus, coronary artery mitochondria emerge as therapeutic targets to improve microvascular perfusion and mitigate progression to heart failure in obesity.
    Keywords:  Coronary arteries; Endoplasmic reticulum stress; Endothelial dysfunction; Mitochondrial dysfunction; Obesity; Oxidative stress
    DOI:  https://doi.org/10.1007/s00395-026-01213-5
  4. J Biol Chem. 2026 Nov 04. pii: S0021-9258(26)02607-4. [Epub ahead of print] 113735
      Mitochondrial dysfunction and oxidative stress are central drivers of photoreceptor degeneration in retinal diseases. Cone photoreceptors are particularly susceptible because of their high metabolic demands and dependence on mitochondrial energy production and metabolism. Primate cone photoreceptors uniquely accumulate carotenoids, yet the mechanism by which these pigments support photoreceptor function and maintenance has remained elusive. We recently identified GRAMD1B, a non-vesicular lipid transport protein that is highly expressed in human photoreceptors and mediates the delivery of carotenoids to mitochondria. We therefore hypothesized that mitochondrial targeting of zeaxanthin enhances the resilience of photoreceptors to oxidative stress. To test this hypothesis, we established a gain-of-function model by expressing human GRAMD1B in 661W murine cone photoreceptor cells, which lack endogenous GRAMD1B. GRAMD1B expression was associated with reduced plasma membrane and increased mitochondrial zeaxanthin and fundamentally reshaped the transcriptional response to blue light-induced stress. Mitochondrial zeaxanthin targeting preferentially activated pathways involved in oxidative phosphorylation, ferroptosis, sphingolipid metabolism, and mitochondrial stress adaptation. Functionally, GRAMD1B-mediated carotenoid transport altered mitochondrial membrane potential, enhanced adaptive redox signaling through the NRF2-HO-1 pathway, and improved cell survival following photo-oxidative stress. In contrast, parental 661W cells contained lower mitochondrial zeaxanthin and mounted primarily extra-mitochondrial stress responses. Together, these findings identify a novel function of GRAMD1B and carotenoids in mitochondrial biology with important implications for retinal health and disease.
    Keywords:  Carotenoids; GRAMD1B; Mitochondria; Photoreceptors; ROS
    DOI:  https://doi.org/10.1016/j.jbc.2026.113735
  5. Front Aging Neurosci. 2026 ;18 1903701
       Introduction: In humans, aging is associated with an increased risk of developing neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's disease (AD). In neurons, the effect of aging on intrinsic molecular processes, and how they tie to age-related neurodegeneration remains unclear. Animal studies have shown that mitochondrial function decline, autophagy impairment and defective elimination of damaged mitochondria by mitophagy are all central features of neuronal aging. However, very few studies have investigated such events in human neurons, due to a lack of models showing aging features. Therefore, there is a crucial need for a better understanding of the effect of aging on neuronal health.
    Methods: Here, we use direct neuronal reprogramming, which maintains signatures of cellular aging, to study the effect of aging on mitochondrial health and mitophagy in human neurons derived from healthy donors ranging from 11 to 91 years old. We use confocal imaging to assess colocalization of mitochondria with autophagic structures following mitophagy induction.
    Results: We show age-related mitochondrial impairment in neurites of induced neurons (iNs) derived from older donors. Additionally, in these neurites, we show an accumulation of mitochondria targeted for degradation in autophagosomes and LAMP1-positive lysosomal vesicles following mitophagy induction. These impairments culminate into incomplete elimination of damaged mitochondria, despite preserved activity of the lysosomal enzymes assessed.
    Conclusion: This study shows for the first time age-related mitophagy impairment in human neurons, and confirms findings of age-related mitochondrial impairments in human neurons. By doing so, this study paves the way for more in-depth mechanistic studies that would allow for the identification of therapeutic targets for anti-aging treatment and in the context of age-associated neurodegenerative diseases.
    Keywords:  aging; direct neuronal reprogramming; human neurons; induced neurons; lysosomal function; mitochondria; mitochondrial health; mitophagy
    DOI:  https://doi.org/10.3389/fnagi.2026.1903701
  6. Front Physiol. 2026 ;17 1975785
      Atherosclerosis (AS) is a vascular disease characterized by lipid accumulation, chronic inflammation, and plaque instability, which can lead to severe cardiovascular events, such as myocardial infarction and stroke. Macrophages are the predominant immune cells within plaques and form foam cells upon uptake of oxidized low-density lipoprotein, a critical driver of AS progression. Recent studies have confirmed that imbalance of the mitochondrial quality control (MQC) system participates in the initiation and progression of AS; however, the imbalance in macrophage MQC as an upstream regulatory mechanism has not yet been systematically elucidated. MQC encompasses mitophagy, fusion-fission balance, mitochondrial biogenesis, and mitochondrial DNA (mtDNA) homeostasis. This imbalance can result in impaired clearance of damaged mitochondria, dysfunction of the electron transport chain, and excessive production of reactive oxygen species (ROS), which in turn activate the NLRP3 inflammasome and trigger inflammation and apoptosis. Concurrently, mitochondrial metabolic reprogramming can promote macrophage polarization toward the pro-inflammatory M1 phenotype while suppressing the anti-inflammatory M2 phenotype, thereby exacerbating lipid deposition and inflammatory amplification. Plaque macrophages are, however, heterogeneous: TREM2-high foamy macrophages are typically less inflammatory and metabolically distinct from adjacent non-foamy macrophages, cautioning against a purely linear glycolysis-M1-foam-cell sequence. Current research predominantly focuses on MQC imbalance, whereas a systematic integration of how imbalances in the MQC network mediate macrophage inflammation, foam cell formation, and plaque progression remains lacking. Intervention strategies targeting mitophagy activation, restoration of mitochondrial fusion-fission homeostasis, mitochondrial antioxidant defense, and macrophage-targeted delivery have demonstrated potential for alleviating plaque burden and stabilizing vulnerable plaques in preclinical studies. This review systematically summarizes the role and molecular mechanisms of macrophage MQC imbalance in AS, outlines existing controversies, research gaps, and novel targeted intervention strategies, and provides a theoretical basis for the development of new therapeutic targets for AS prevention and treatment.
    Keywords:  Mitochondrial quality control; NLRP3 inflammasome; atherosclerosis; macrophage polarization; macrophages; mitochondrial DNA; mitophagy; reactive oxygen species
    DOI:  https://doi.org/10.3389/fphys.2026.1975785
  7. PeerJ. 2026 ;14 e21873
      Insulin resistance (IR) is characterized by impaired insulin responsiveness in metabolic tissues, leading to defective glucose disposal, dysregulated lipid metabolism, and compensatory hyperinsulinemia. Mitochondrial iron homeostasis is crucial for cellular metabolism, oxidative phosphorylation (OXPHOS), and redox balance. Dysregulation of mitochondrial iron contributes to IR by impairing electron transport chain (ETC) function, increasing reactive oxygen species (ROS), and disrupting insulin signaling pathways. Excess mitochondrial iron leads to oxidative stress through the Fenton reaction, promoting lipid peroxidation, mitochondrial dysfunction, and inflammation, all of which exacerbate metabolic disorders. Additionally, mitochondrial iron overload affects iron-sulfur (Fe-S) cluster biosynthesis, mitochondrial dynamics, and energy metabolism, further impairing glucose homeostasis. Emerging evidence suggests that mitochondrial iron dysregulation plays a pivotal role in the pathogenesis of type 2 diabetes mellitus (T2DM) and metabolic syndrome. Future research should focus on the molecular mechanisms governing mitochondrial iron transport and utilization, as well as its interaction with key metabolic pathways, to better understand its role in disease progression and potential therapeutic implications.
    Keywords:  Insulin resistance; Mitochondrial dysfunction; Mitochondrial iron; Mitoferrin; Redox system
    DOI:  https://doi.org/10.7717/peerj.21873
  8. Biol Res Nurs. 2026 Nov 02. 10998004261500758
      BackgroundCreatine monohydrate supplementation (CrM) has been shown to increase brain creatine levels, which may augment brain bioenergetics and improve cognitive functioning over time. However, whether creatine-mediated cognitive benefits are age-dependent remains unclear.AimThe purpose of this study was to investigate the effects of CrM on measures of cognitive functioning in young and older women.MethodsForty-eight women (26 young, 22 old) were randomly assigned to 28-day CrM supplementation (3 grams/day) or placebo. Cognitive functioning was assessed using a battery of tests before and after supplementation. Inferential and Bayesian analyses were applied for group comparisons. The between-group comparisons were carried out using a linear mixed model with groups as fixed factors and estimated daily creatine consumption as a random factor, since there were significant differences among groups in estimated daily creatine consumption at baseline. The significance level was set as p < 0.05. The Bayesian analysis checked the magnitude of the evidence.ResultsAcross this exploratory, multi-domain battery, CrM supplementation was associated with improvements in several cognitive parameters in both age groups compared to placebo, most consistently in visual and auditory reaction times, inhibitory control, and working memory. These frequentist findings were corroborated by moderate-to-extreme Bayesian evidence in a subset of comparisons, particularly among older females, suggesting a possible role for CrM in mitigating age-related cognitive decline that warrants confirmation in future, hypothesis-driven trials.SummaryThese findings demonstrate the potential cognitive benefits of low-dose CrM supplementation in women across age groups and highlight the greater cognitive responses in older females.
    Keywords:  aging; creatine; memory; neuroscience; working memory
    DOI:  https://doi.org/10.1177/10998004261500758
  9. Placenta. 2026 Oct 24. pii: S0143-4004(26)00728-9. [Epub ahead of print]186 223-232
       BACKGROUND: In Preeclampsia (PE), the mechanisms linking placental injury to maternal vascular inflammation remain incompletely understood. Circulating cell-free mitochondrial DNA (ccf-mtDNA), released from damaged or ischemic placental mitochondria, may function as a damage-associated molecular pattern and activate Toll-like receptor 9 (TLR9).
    METHODS: In this case-control study, 150 women with PE, 150 non-PE pregnant women, and 50 non-pregnant women were evaluated. Plasma ccf-mtDNA copy number was quantified by quantitative real-time PCR targeting mitochondrial ND1 gene and normalised to 36B4. Placental TLR9 expression was assessed by qRT-PCR and immunohistochemistry (n = 10/group). Human placental vascular endothelial cells (HPVECs) were treated with a TLR9 agonist (ODN 2395), antagonist (ODN A151), or plasma from PE and non-PE women (n = 10/group). Protein carbonylation, lipid peroxidation, and secretion of IL-6, TNF-α, and IL-10 were assessed.
    RESULTS: Plasma ccf-mtDNA copy number was significantly higher in PE than in non-PE pregnant and non-pregnant women, showing a progressive stepwise increase across groups (p < 0.001). Placental TLR9 mRNA and protein expression were significantly increased in PE (p ≤ 0.0013). TLR9 agonism significantly increased protein carbonylation, malondialdehyde, IL-6, TNF-α, and IL-10 in HPVECs (all p < 0.0001). PE plasma produced similar effects, which were significantly attenuated by TLR9 antagonism (p < 0.05). Responses to non-PE plasma were weaker and less consistently inhibited by TLR9 blockade.
    CONCLUSIONS: PE is associated with increased circulating mitochondrial DNA and placental TLR9 expression. The findings support a potential ccf-mtDNA-TLR9 pathway linking placental mitochondrial injury to endothelial oxidative stress and inflammatory responses, suggesting TLR9-mediated innate immune activation as a potential mechanistic and therapeutic target in PE.
    Keywords:  Circulating cell-free mitochondrial DNA; Endothelial dysfunction; Oxidative stress; Placenta; Preeclampsia; Toll-like receptor 9
    DOI:  https://doi.org/10.1016/j.placenta.2026.10.011
  10. J Neuroendocrinol. 2026 Nov;pii: e70309. [Epub ahead of print]38(11):
      Early-life adversity increases risk for disease with sex-specific effects on brain development. While the association between early-life stress and neuropsychiatric disorders is well established, its impact on respiratory health is poorly documented, particularly in females. Here, we review recent studies using neonatal maternal separation (NMS) to examine the long-term consequences of early-life stress on cardiorespiratory function in females. Panic disorder (PD) is an anxiety disorder that is ⁓2 times more prevalent in women. The respiratory subtype is characterised by an exaggerated ventilatory response to CO2. NMS augmented the response to 5% CO2 of adult female rats; this effect was most pronounced during proestrus and absent in males. Orexin (ORX) neurons potentiate the CO2 response and are normally inhibited by 17β-estradiol (E2). Electrophysiological measurements showed that in control females, excitatory postsynaptic current frequency varied inversely with E2 levels. However, NMS disrupted this E2-mediated inhibition, particularly during proestrus, implicating impaired estrogen action in PD-related respiratory dysfunction. Age-related ovarian decline increases the risk of sleep apnea and associated comorbidities. Whereas apnea frequency decreased with age in control females, 1 year-old NMS females exhibited a 75% higher apnea index than age-matched controls, together with greater adiposity and hypertension. Arterial pressure was inversely correlated with circulating E2 levels only in NMS females, indicating heightened vulnerability to age-related estrogen decline. Although physiological fluctuations in E2 levels exert modest effects in healthy females, we propose that early-life stress persistently alters responsiveness to E2 and acts synergistically with ageing to increase cardiovascular vulnerability throughout the female lifespan.
    Keywords:  ageing; hypertension; neonatal maternal separation; panic disorder; sleep apnea
    DOI:  https://doi.org/10.1111/jne.70309
  11. Transl Psychiatry. 2026 Aug 06. pii: 607. [Epub ahead of print]16(1):
      Premature epigenetic aging has been linked to poorer cognitive performance, but the neuroanatomical pathways underlying this association remain unclear. Therefore, we tested whether premature epigenetic aging predicts deviations from normative brain development and cognition in young adulthood. We followed 254 young adults from the ELSPAC prenatal birth cohort. Epigenetic aging was estimated using Horvath's DNA methylation clock, CheekAge, and AltumAge. Structural MRI was processed with FreeSurfer to derive cortical thickness and surface area in 68 Desikan-Killiany regions and subcortical volumes in 14 Aseg regions. CentileBrain normative models trained on 37,407 MRI scans from individuals aged 3-90 years were used to quantify age- and sex-specific deviations from normative brain development. Cognitive performance was assessed using the WAIS-IV. Premature epigenetic aging estimated using Horvath's clock was associated with more negative deviations from normative volume of the putamen and caudate, but not with other subcortical volumes, cortical thickness, or surface area. In women, this premature epigenetic aging was also associated with lower full-scale IQ and performance IQ, and moderated mediation analyses indicated that the deviations in putamen volume mediated the relationship between premature epigenetic aging and cognitive performance. In men, the relationship between premature epigenetic aging and cognitive performance was quadratic (U-shaped). No similar effects were observed when using CheekAge or AltumAge.Premature epigenetic aging estimated using Horvath's clock and the associated deviations in development of the dorsal striatum in young adulthood may represent an early marker of poorer cognitive performance long before clinical symptoms might emerge.
    DOI:  https://doi.org/10.1038/s41398-026-04337-3
  12. EMBO Rep. 2026 Nov 02.
      Mechanisms linking amyloid peptides to mitochondrial dysfunction and impaired mitophagy in Alzheimer's disease (AD) remain poorly defined. Here, we report that, in healthy aging neurons, mitochondrial ceramide synthase 1 (CerS1) localization accompanies increased mitochondrial C18-ceramide and mitophagy in damaged mitochondria. In neuronal, mouse, and human AD tissues, amyloid precursor protein (APP) or Aβ40, but not Aβ42, shows increased proximity or co-association with TOM20/TOM40 alongside reduced mitochondrial CerS1/C18-ceramide accumulation and mitophagy. Mitochondria-excluded mutant APP does not reproduce these responses in neuronal cells. WT-APP expression is associated with reduced p17/PERMIT-ICT1 proximity, which does not establish direct APP-ICT1 binding or disruption of complex formation. Reduced mitophagy also accompanies lysosomal Aβ42 accumulation and secretion from neurons. Aged CerS1top/top mice, expressing catalytically inactive CerS1, exhibit mitochondrial dysfunction, behavioral deficits, and amyloid-positive plaque accumulation. Treatment with the peptide-targeted nanoparticle Pen-Cera-LCL768, which accumulates in the brain after intranasal administration, increases mitophagy-related readouts, reduces plaque burden, and improves behavioral performance in aged 3xTg and CerS1top/top mice. Mdivi-1 attenuates treatment effects in 3xTg mice, but its lack of specificity limits conclusions about mitophagy dependence.
    DOI:  https://doi.org/10.1038/s44319-026-00984-1
  13. Med Sci Sports Exerc. 2026 Nov 03.
       INTRODUCTION: There is considerable evidence that physical activity can stimulate mitochondrial biogenesis in muscles, enhance maximal mitochondrial oxygen consumption rate, improve physical fitness, and help maintain overall health in humans. On the other hand, there is growing evidence that excessive training load may have a detrimental effect on mitochondria and glucose homeostasis.
    HYPOTHESIS: We hypothesized that moderate-intensity interval training (MIIT) would be sufficient to increase muscle mitochondrial oxidative capacity and exercise tolerance in untrained healthy people.
    METHODS: Eleven young, healthy, untrained males took part in this study. They performed a 7-week endurance training program (MIIT) on a cycle ergometer, composed of 4 sessions per week, each lasting 40 min. Before and after the MIIT training program, a pulmonary maximal oxygen consumption (V̇O2max) as well as lactate threshold (LT) were determined and a muscle biopsy from the m. vastus lateralis was taken to evaluate the level of muscle proteins related to energy metabolism and mitochondrial biogenesis, and to measure the muscle's maximal mitochondrial respiration rate.
    RESULTS: The training resulted in an increase of skeletal muscle homogenate V̇O2max (by ~50%, P=0.001), due to increased mitochondrial mass and the enrichment of mitochondria with the individual respiratory chain complexes. The MIIT increased the power output at the lactate threshold (PO at LT) by ~43 W (P=0.001) and the pulmonary V̇O2max by 7% (P=0.01) and had no adverse effect on blood glucose homeostasis.
    CONCLUSIONS: MIIT, which is a less intense form of training than the commonly used types of interval training, effectively induces a range of beneficial muscular and systemic adaptations that contribute to improvement of physical fitness and maintenances good health in humans.
    Keywords:  BIOENERGETICS; EXERCISE; INSULIN SENSITIVITY; LACTATE THRESHOLD; MAXIMAL OXYGEN UPTAKE; MITOCHONDRIAL BIOGENESIS; RESPIRATORY EXCHANGE RATIO
    DOI:  https://doi.org/10.1249/MSS.0000000000004203